JP2017522288A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017522288A5 JP2017522288A5 JP2016573587A JP2016573587A JP2017522288A5 JP 2017522288 A5 JP2017522288 A5 JP 2017522288A5 JP 2016573587 A JP2016573587 A JP 2016573587A JP 2016573587 A JP2016573587 A JP 2016573587A JP 2017522288 A5 JP2017522288 A5 JP 2017522288A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- bmdsc
- use according
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010051909 Endometrial atrophy Diseases 0.000 claims description 9
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims description 8
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 8
- 210000000685 uterine artery Anatomy 0.000 claims description 7
- 238000002617 apheresis Methods 0.000 claims description 5
- 210000001185 bone marrow Anatomy 0.000 claims description 5
- 210000005259 peripheral blood Anatomy 0.000 claims description 5
- 239000011886 peripheral blood Substances 0.000 claims description 5
- 210000002565 arteriole Anatomy 0.000 claims description 4
- 230000032692 embryo implantation Effects 0.000 claims description 4
- 230000001483 mobilizing effect Effects 0.000 claims description 4
- 230000003054 hormonal effect Effects 0.000 claims description 3
- 210000000130 stem cell Anatomy 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims 14
- 208000028685 Asherman syndrome Diseases 0.000 claims 2
- 208000002777 Gynatresia Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 description 19
- 230000002357 endometrial effect Effects 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 3
- 230000003836 peripheral circulation Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462013121P | 2014-06-17 | 2014-06-17 | |
| US62/013,121 | 2014-06-17 | ||
| PCT/IB2015/001715 WO2015193737A1 (en) | 2014-06-17 | 2015-06-05 | Stem cell therapy in endometrial pathologies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020102340A Division JP2020138984A (ja) | 2014-06-17 | 2020-06-12 | 子宮内膜病変における幹細胞治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017522288A JP2017522288A (ja) | 2017-08-10 |
| JP2017522288A5 true JP2017522288A5 (enExample) | 2018-07-12 |
| JP6920062B2 JP6920062B2 (ja) | 2021-08-18 |
Family
ID=54329860
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016573587A Active JP6920062B2 (ja) | 2014-06-17 | 2015-06-05 | 子宮内膜病変における幹細胞治療 |
| JP2020102340A Pending JP2020138984A (ja) | 2014-06-17 | 2020-06-12 | 子宮内膜病変における幹細胞治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020102340A Pending JP2020138984A (ja) | 2014-06-17 | 2020-06-12 | 子宮内膜病変における幹細胞治療 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11129851B2 (enExample) |
| EP (3) | EP3158057B1 (enExample) |
| JP (2) | JP6920062B2 (enExample) |
| CN (2) | CN116747241A (enExample) |
| AU (1) | AU2015275798B2 (enExample) |
| BR (1) | BR112016029558A2 (enExample) |
| CA (1) | CA2952559C (enExample) |
| CY (2) | CY1122615T1 (enExample) |
| DK (2) | DK3569697T3 (enExample) |
| ES (3) | ES2983444T3 (enExample) |
| HR (3) | HRP20240798T1 (enExample) |
| HU (3) | HUE044823T2 (enExample) |
| LT (2) | LT3158057T (enExample) |
| MX (1) | MX377300B (enExample) |
| PL (3) | PL3569697T3 (enExample) |
| PT (2) | PT3569697T (enExample) |
| RS (3) | RS59210B1 (enExample) |
| RU (1) | RU2725006C2 (enExample) |
| SI (2) | SI3569697T1 (enExample) |
| SM (3) | SMT202400270T1 (enExample) |
| TR (1) | TR201910410T4 (enExample) |
| WO (1) | WO2015193737A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| BR112014030750A2 (pt) | 2012-06-06 | 2017-08-22 | Inst Catalana Recerca Estudis Avancats | Método para diagnóstico, prognóstico e tratamento da metástase do câncer pulmonar |
| HK1213946A1 (zh) | 2012-10-12 | 2016-07-15 | Inbiomotion S.L. | 用於使用c-maf对前列腺癌转移进行诊断、预後和治疗的方法 |
| US10119171B2 (en) | 2012-10-12 | 2018-11-06 | Inbiomotion S.L. | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis |
| AU2014229563B2 (en) | 2013-03-15 | 2020-04-09 | Fundacio Institut De Recerca Biomedica (Irb Barcelona) | Method for the diagnosis, prognosis and treatment of cancer metastasis |
| SMT202400270T1 (it) | 2014-06-17 | 2024-07-09 | Asherman Therapy S L | Terapia con cellule staminali in patologie endometriali |
| RU2771328C2 (ru) * | 2016-06-23 | 2022-04-29 | Титон Биотек, Инк. | Клетки, экспрессирующие рецептор паратиреоидного гормона 1, и их применение |
| RU2699029C1 (ru) * | 2018-12-10 | 2019-09-03 | Частное образовательное учреждение дополнительного профессионального образования "Академия медицинского образования имени Федора Ивановича Иноземцева" (ЧОУ ДПО "Академия медицинского образования им. Ф.И. Иноземцева") | Способ использования мезенхимальных стволовых клеток для улучшения состояния рубца на матке |
| RU2741621C1 (ru) * | 2020-09-25 | 2021-01-28 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации | Способ лечения внутриматочных синехий |
| US20250000909A1 (en) | 2021-07-23 | 2025-01-02 | Cha University Industry-Academic Cooperation Foundation | Pharmaceutical composition for preventing or treating asherman's syndrome comprising isolated mitochondria as active ingredient |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69027992D1 (de) | 1989-05-05 | 1996-09-05 | North Sydney Area Health Serv | Steigerung der fruchtbarkeit |
| US6979533B2 (en) | 1992-06-12 | 2005-12-27 | The Trustees Of The University Of Pennsylvania | Determination of endometrial receptivity toward embryo implantation |
| CA2203718A1 (en) | 1997-04-25 | 1998-10-25 | University Of British Columbia | Cadherin-11 as an indicator of viable pregnancy |
| IL127896A0 (en) | 1998-12-31 | 1999-10-28 | Gail Laster | A novel treatment for preeclampsia and related diseases |
| IL151265A0 (en) | 2000-03-08 | 2003-04-10 | Kliman Harvey J | Methods of diagnosing and monitoring endometrial glandular development |
| JP2004504275A (ja) | 2000-05-24 | 2004-02-12 | シエーリング アクチエンゲゼルシャフト | フィブリン−１の医薬用途 |
| US6780594B2 (en) | 2000-09-25 | 2004-08-24 | Schering Aktiengesellschaft | Method for in vitro diagnosis of endometriosis |
| AUPR673001A0 (en) | 2001-07-31 | 2001-08-23 | Prince Henry's Institute Of Medical Research | Pregnancy-related enzyme activity |
| DE10139874A1 (de) | 2001-08-10 | 2003-04-30 | Schering Ag | Humane Mater-Proteine |
| GB0201284D0 (en) | 2002-01-21 | 2002-03-06 | Isis Innovation | Screening methods for contraceptive and fertility agents |
| US20030186300A1 (en) | 2002-03-20 | 2003-10-02 | Ali Akoum | Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions |
| US20040005612A1 (en) | 2002-05-14 | 2004-01-08 | Giudice Linda C. | Endometrial genes in endometrial disorders |
| ES2273061T3 (es) | 2002-08-02 | 2007-05-01 | Schering Aktiengesellschaft | Agentes moduladores de receptores de progesterona con actividad antigonadotropa elevada para el control de fertilidad femenina y para la terapia por reemplazo hormonal. |
| DE10236405A1 (de) | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
| AU2003303347A1 (en) | 2002-12-21 | 2004-07-22 | Universitat Leipzig | Method and means for determining specific conditions or changes in the uterine epithelium and in the epithelium of other organs |
| WO2005018796A1 (en) | 2003-08-21 | 2005-03-03 | Pamgene B.V. | Microarray support for bioprobe synthesis |
| JP2007504807A (ja) | 2003-09-08 | 2007-03-08 | ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | 培養培地にプロスタグランジン又はプロスタグランジン類似物を補足することによってインビトロ胚発生を高めるための方法及び組成 |
| WO2005026324A2 (en) | 2003-09-08 | 2005-03-24 | The Board Of Regents Of The University Of Texas System | Method and composition for enhancing in vitro embryo development by supplementing culture medium with prostaglandin or a prostaglandin analog |
| US20080226554A1 (en) | 2003-12-23 | 2008-09-18 | Mount Sinai Hospital | Methods For Detecting Markers Associated With Endometrial Disease or Phase |
| EP1765083A4 (en) | 2004-05-28 | 2008-08-20 | Serono Lab | USE OF IL-17 TO TREAT FERTILITY DISORDERS |
| CN101460199B (zh) * | 2006-03-31 | 2011-06-08 | 皇家飞利浦电子股份有限公司 | 利用超短t2*弛豫进行细胞测量的系统和方法 |
| JP2007278750A (ja) | 2006-04-04 | 2007-10-25 | Ono Pharmaceut Co Ltd | プロスタグランジン類及びその類縁体の定量方法 |
| WO2008036374A2 (en) * | 2006-09-21 | 2008-03-27 | Medistem Laboratories, Inc. | Allogeneic stem cell transplants in non-conditioned recipients |
| GB0703683D0 (en) * | 2007-02-26 | 2007-04-04 | Ark Therapeutics Ltd | The treatment of complications in pregnancy |
| US9259233B2 (en) * | 2007-04-06 | 2016-02-16 | Hologic, Inc. | Method and device for distending a gynecological cavity |
| US8673850B2 (en) | 2008-05-30 | 2014-03-18 | Institut De Recherches Cliniques De Montreal | PCSK9 inhibitors and methods of use thereof |
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| WO2013166281A1 (en) * | 2012-05-02 | 2013-11-07 | Cedars-Sinai Medical Center | Bi-functional compositions for targeting cells to diseased tissues and methods of using same |
| EP2348318A1 (en) | 2010-01-21 | 2011-07-27 | Equipo Ivi Investigación, S.L. | Diagnostic method for endometrial receptivity |
| EP2768976B1 (en) | 2011-10-21 | 2018-01-10 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for assessing endometrial receptivity of a patient after controlled ovarian hyperstimulation |
| KR20140106550A (ko) | 2011-11-30 | 2014-09-03 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 생물학적 모니터링을 위한 ｇｍ1 갱글리오사이드와 아넥신 ⅴ 마이크로입자 폴리펩타이드 비율 |
| EP2867670B1 (en) | 2012-06-27 | 2018-05-30 | Roche Diagnostics GmbH | MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD |
| RU2515475C1 (ru) * | 2012-11-15 | 2014-05-10 | Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК | Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте |
| US20170097358A1 (en) | 2014-03-21 | 2017-04-06 | Igenomix S.L. | Early detection of preeclampsia |
| SMT202400270T1 (it) | 2014-06-17 | 2024-07-09 | Asherman Therapy S L | Terapia con cellule staminali in patologie endometriali |
-
2015
- 2015-06-05 SM SM20240270T patent/SMT202400270T1/it unknown
- 2015-06-05 PT PT191693092T patent/PT3569697T/pt unknown
- 2015-06-05 PT PT15781411T patent/PT3158057T/pt unknown
- 2015-06-05 SI SI201531822T patent/SI3569697T1/sl unknown
- 2015-06-05 LT LTEP15781411.2T patent/LT3158057T/lt unknown
- 2015-06-05 US US15/318,825 patent/US11129851B2/en active Active
- 2015-06-05 MX MX2016016756A patent/MX377300B/es active IP Right Grant
- 2015-06-05 HR HRP20240798TT patent/HRP20240798T1/hr unknown
- 2015-06-05 EP EP15781411.2A patent/EP3158057B1/en active Active
- 2015-06-05 RS RSP20190913 patent/RS59210B1/sr unknown
- 2015-06-05 BR BR112016029558A patent/BR112016029558A2/pt not_active Application Discontinuation
- 2015-06-05 ES ES22150013T patent/ES2983444T3/es active Active
- 2015-06-05 RS RS20240690A patent/RS65719B1/sr unknown
- 2015-06-05 PL PL19169309T patent/PL3569697T3/pl unknown
- 2015-06-05 PL PL15781411T patent/PL3158057T3/pl unknown
- 2015-06-05 CA CA2952559A patent/CA2952559C/en active Active
- 2015-06-05 SI SI201530822T patent/SI3158057T1/sl unknown
- 2015-06-05 SM SM20190400T patent/SMT201900400T1/it unknown
- 2015-06-05 ES ES15781411T patent/ES2736117T3/es active Active
- 2015-06-05 HU HUE15781411 patent/HUE044823T2/hu unknown
- 2015-06-05 JP JP2016573587A patent/JP6920062B2/ja active Active
- 2015-06-05 DK DK19169309.2T patent/DK3569697T3/da active
- 2015-06-05 HU HUE22150013A patent/HUE067463T2/hu unknown
- 2015-06-05 CN CN202310575540.1A patent/CN116747241A/zh active Pending
- 2015-06-05 TR TR2019/10410T patent/TR201910410T4/tr unknown
- 2015-06-05 WO PCT/IB2015/001715 patent/WO2015193737A1/en not_active Ceased
- 2015-06-05 HR HRP20191240 patent/HRP20191240T1/hr unknown
- 2015-06-05 ES ES19169309T patent/ES2910306T3/es active Active
- 2015-06-05 HU HUE19169309A patent/HUE058328T2/hu unknown
- 2015-06-05 CN CN201580043147.1A patent/CN107073040A/zh active Pending
- 2015-06-05 RS RS20220339A patent/RS63093B1/sr unknown
- 2015-06-05 RU RU2017101147A patent/RU2725006C2/ru active
- 2015-06-05 EP EP22150013.5A patent/EP4012023B1/en active Active
- 2015-06-05 PL PL22150013.5T patent/PL4012023T3/pl unknown
- 2015-06-05 AU AU2015275798A patent/AU2015275798B2/en active Active
- 2015-06-05 LT LTEP19169309.2T patent/LT3569697T/lt unknown
- 2015-06-05 DK DK15781411.2T patent/DK3158057T3/da active
- 2015-06-05 EP EP19169309.2A patent/EP3569697B8/en active Active
- 2015-06-05 HR HRP20220419TT patent/HRP20220419T1/hr unknown
- 2015-06-05 SM SM20220155T patent/SMT202200155T1/it unknown
-
2019
- 2019-07-16 CY CY20191100753T patent/CY1122615T1/el unknown
-
2020
- 2020-06-12 JP JP2020102340A patent/JP2020138984A/ja active Pending
-
2022
- 2022-04-05 CY CY20221100258T patent/CY1125938T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017522288A5 (enExample) | ||
| JP2015131795A5 (enExample) | ||
| RU2017101147A (ru) | Терапия стволовыми клетками при патологиях эндометрия | |
| MX2025008493A (es) | Agentes de union a fibroblastos y uso de estos | |
| Terai et al. | Status of and candidates for cell therapy in liver cirrhosis: overcoming the “point of no return” in advanced liver cirrhosis | |
| EA201991692A1 (ru) | Иммуносконструированные плюрипотентные клетки | |
| MX339469B (es) | Agentes inductores de apotosis para el tratamiento de cancer y enfermedades inmunes y autoinmunes. | |
| MX2013004817A (es) | Enfermedad inflamatoria. | |
| PH12021552887A1 (en) | Modified viral particles and uses thereof | |
| Singhal et al. | Endothelial cell fitness dictates the source of regenerating liver vasculature | |
| MY157564A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| EA201891931A1 (ru) | Новые ингибиторы фосфатидилинозитол-3-киназы гамма | |
| Galipeau | Mesenchymal stromal cells for graft-versus-host disease: a trilogy | |
| MY178445A (en) | Novel antibody binding to tfpi and composition comprising the same | |
| JP2017507145A5 (enExample) | ||
| Kim et al. | Pharmacoeconomic impact of up-front use of plerixafor for autologous stem cell mobilization in patients with multiple myeloma | |
| CN111770924A (zh) | 用于治疗乳腺癌的雌激素受体降解剂 | |
| WO2019055776A3 (en) | Compositions and methods for treatment of diseases involving cxcl1 function | |
| WO2016066722A3 (en) | Bacteriophage combinations for human or animal therapy | |
| NZ702666A (en) | A method of weight reduction | |
| King et al. | Bone marrow stem cell therapy for liver disease | |
| JP2018509479A5 (enExample) | ||
| Salem et al. | Vascular Complications after Adult to Adult Living Donor Liver Transplantation: Single Center Experience.: Abstract# P-704 | |
| Wang et al. | Abstract No. 30: Superselective transhepatic arterial chemoembolization for hepatocellular carcinoma in high risk patients as a bridge towards liver transplantation | |
| Rodriguez | Interferon-α |